Orobiq HCT Tablets 5/40/12.5 mg

Adult dose

This medication is taken once daily, with or without food, along with water. It is recommended to take it at the same time each day (e.g., morning) if possible. The recommended dosage is as follows: - 5/20/12.5 mg: for patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan medoxomil 5/20 mg combined therapy. - 5/40/12.5 mg: for patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan medoxomil 5/40 mg combined therapy.

Child dose

The safety and efficacy of this medication in patients under 18 years of age have not been established, and its use is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so discontinuation is necessary as soon as pregnancy is confirmed. Patients who have allergies or hypersensitivity to this medication or any of its ingredients should not use it. Patients with certain conditions such as pregnant or breastfeeding women, patients with severe hypotension, severe heart valve disease, acute heart failure, or severely impaired kidney or liver function should avoid taking this medication as it may be dangerous. Patients with reduced blood volume, renal problems, or impaired liver function should exercise caution when using this medication, and their condition should be closely monitored. As this medication lowers blood pressure, symptoms of hypotension may occur, so caution should be exercised when driving or operating hazardous machinery. This medication can affect electrolyte levels in the blood, so regular blood tests should be conducted to monitor electrolyte status. While taking this medication, interactions may occur with certain drugs, so if other medications are being used, consultation with a doctor or pharmacist is essential. The safety and efficacy of this medication in children have not been established, so it is not recommended for patients under 18 years of age. Elderly patients may respond more sensitively to this medication due to decreased kidney and liver function and should start at a lower dose and take it cautiously. Overdose may result in symptoms such as hypotension, palpitations, and bradycardia; if these symptoms occur, immediate medical attention should be sought for appropriate treatment. This medication should be stored away from direct sunlight and moisture, and kept out of reach of children, and transferring it to another container should be avoided.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties accompanied by cough and fever, jaundice (yellowing of the skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Light yellow round film-coated tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu×3]